shasha david CORD-Authors (Version 1)

Author: Shasha, David
Email: shashad@meuhedet.co.il
Affiliation: Tel Aviv University
link: https://covid19-data.nist.gov/pid/rest/local/institution/tel_aviv_university
Paper Title: BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study
Paper Link: https://covid19-data.nist.gov/pid/rest/local/paper/bnt162b2_vaccine_effectiveness_in_preventing_asymptomatic_infection_with_sars_cov_2
Paper Title: Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection
Paper Link: https://covid19-data.nist.gov/pid/rest/local/paper/anosmia_and_dysgeusia_in_patients_with_mild_sars_cov_2_infection
Paper Title: Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy a Single Center Prospective Cohort Study
Paper Link: https://covid19-data.nist.gov/pid/rest/local/paper/safety_and_immunogenicity_of_the_bnt162b2_mrna_covid_19_vaccine_in_patients_after
Paper Title: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study
Paper Link: https://covid19-data.nist.gov/pid/rest/local/paper/real_world_safety_data_for_the_pfizer_bnt162b2_sars_cov_2_vaccine_historical_cohort
Paper Title: Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection
Paper Link: https://covid19-data.nist.gov/pid/rest/local/paper/time_course_of_anosmia_and_dysgeusia_in_patients_with_mild_sars_cov_2_infection